Literature DB >> 2117123

Long-term drug treatment of asthma in children.

K F Kerrebijn1.   

Abstract

In this short review the pharmacologic and clinical effect of antiasthma drugs in children that is, beta 2-agonists, theophylline, anticholinergics, disodiumcromoglycate/nedocromil sodium, and inhaled corticosteroids are described. Furthermore, a medication plan for maintenance treatment is presented.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2117123     DOI: 10.1007/bf02718127

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  47 in total

1.  Xanthines as airway anti-inflammatory drugs.

Authors:  C G Persson; A B Draco
Journal:  J Allergy Clin Immunol       Date:  1988-03       Impact factor: 10.793

2.  Issues in exercise-induced asthma.

Authors:  S D Anderson
Journal:  J Allergy Clin Immunol       Date:  1985-12       Impact factor: 10.793

3.  The assessment and treatment of asthma: a conference report.

Authors:  F E Hargreave; J Dolovich; M T Newhouse
Journal:  J Allergy Clin Immunol       Date:  1990-06       Impact factor: 10.793

Review 4.  Sodium cromoglycate and related drugs.

Authors:  M K Church; J O Warner
Journal:  Clin Allergy       Date:  1985-07

5.  In vitro responsiveness of human asthmatic bronchus to carbachol, histamine, beta-adrenoceptor agonists and theophylline.

Authors:  R G Goldie; D Spina; P J Henry; K M Lulich; J W Paterson
Journal:  Br J Clin Pharmacol       Date:  1986-12       Impact factor: 4.335

6.  Methylxanthines inhibit exercise-induced bronchoconstriction at low serum theophylline concentration and in a dose-dependent fashion.

Authors:  H Magnussen; G Reuss; R Jörres
Journal:  J Allergy Clin Immunol       Date:  1988-03       Impact factor: 10.793

7.  Pathogenesis of asthma.

Authors:  E R McFadden
Journal:  J Allergy Clin Immunol       Date:  1984-04       Impact factor: 10.793

Review 8.  The asthma syndrome: inciters, inducers, and host characteristics.

Authors:  J Dolovich; F Hargreave
Journal:  Thorax       Date:  1981-09       Impact factor: 9.139

9.  Paradoxical response to nebulised salbutamol in wheezy infants, assessed by partial expiratory flow-volume curves.

Authors:  A Prendiville; S Green; M Silverman
Journal:  Thorax       Date:  1987-02       Impact factor: 9.139

10.  Effects of nedocromil sodium (Tilade) on the activation of human eosinophils and neutrophils and the release of histamine from mast cells.

Authors:  R Moqbel; O Cromwell; G M Walsh; A J Wardlaw; L Kurlak; A B Kay
Journal:  Allergy       Date:  1988-05       Impact factor: 13.146

View more
  6 in total

Review 1.  Pharmacological basis for duration of effect: formoterol and salmeterol versus short-acting beta 2-adrenoceptor agonists.

Authors:  A Lindén; K F Rabe; C G Löfdahl
Journal:  Lung       Date:  1996       Impact factor: 2.584

Review 2.  Clinical pharmacokinetics of salmeterol.

Authors:  Mario Cazzola; Renato Testi; Maria Gabriella Matera
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

3.  Salmeterol, formoterol, and salbutamol in the isolated guinea pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism.

Authors:  A Lindén; A Bergendal; A Ullman; B E Skoogh; C G Löfdahl
Journal:  Thorax       Date:  1993-05       Impact factor: 9.139

4.  Relaxation kinetics of formoterol and salmeterol in the guinea pig trachea in vitro.

Authors:  P Anderson; J Lötvall; A Lindén
Journal:  Lung       Date:  1996       Impact factor: 2.584

5.  Different effects of salmeterol, formoterol and salbutamol on cholinergic responses in the ferret trachea.

Authors:  A Bergendal; A Lindén; J Lötvall; B E Skoogh; C G Löfdahl
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

6.  The effects of formoterol on plasma exudation produced by a localized acute inflammatory response to bradykinin in the tracheal mucosa of rats in vivo.

Authors:  S R O'Donnell; G P Anderson
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.